Valuation: Cutia Therapeutics

Market Cap 623M 727M 92.71M 79.57M 74.69M 68.21M 129M 8.84B 129M 884M 343M 4.46B 348M 341M 14.78B P/E 2026 *
-3.74x
P/E 2027 * 13.2x
Enterprise Value 692M 807M 103M 88.34M 82.92M 75.73M 143M 9.82B 144M 981M 380M 4.95B 386M 378M 16.4B EV / Sales 2026 *
1.07x
EV / Sales 2027 * 0.53x
Free-Float
32.66%
Yield 2026 *
-
Yield 2027 * -
1 day-1.00%
1 week-8.76%
Current month-15.38%
1 month-20.80%
3 months-46.34%
6 months-57.14%
Current year-56.39%
1 week 1.83
Extreme 1.83
2.17
1 month 1.83
Extreme 1.83
2.68
Current year 1.83
Extreme 1.83
5.51
1 year 1.83
Extreme 1.83
12
3 years 1.83
Extreme 1.83
31
5 years 1.83
Extreme 1.83
32.6
10 years 1.83
Extreme 1.83
32.6
Manager TitleAgeSince
Chief Executive Officer 48 01/09/2019
Director of Finance/CFO 36 10/05/2021
Chief Tech/Sci/R&D Officer 42 10/01/2020
Director TitleAgeSince
Director/Board Member 48 12/05/2020
Chairman 63 23/08/2019
Director/Board Member 36 15/11/2022
Date Insider Type Main position Quantity % Market Cap.
15/10/24 Other

Founder

15,000 0.0049%
3/10/24 Other

Chief Financial Officer

20,000 0.0066%
2/10/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%-8.76%-79.46%-92.17% 92.25M
-3.59%-7.10%+61.60%+114.83% 1,100B
-1.15%-1.25%+52.98%+62.41% 658B
-1.09%-1.15%+26.18%+79.22% 470B
-1.47%+0.24%+42.09%+42.09% 372B
-0.90%+0.05%+25.57%+41.75% 304B
-1.94%+1.53%+3.05%+13.24% 264B
-0.43%-0.46%+52.06%+71.75% 239B
-0.93%+1.84%-13.11%-52.28% 213B
-0.46%+0.33%+29.05%+92.67% 184B
Average -1.30%-0.76%+20.00%+37.35% 380.3B
Weighted average by Cap. -1.82%-1.58%+40.53%+68.24%

Financials

2026 *2027 *
Net sales 646M 753M 96.06M 82.45M 77.39M 70.68M 133M 9.16B 134M 916M 355M 4.62B 361M 353M 15.31B 1.18B 1.38B 175M 151M 141M 129M 244M 16.74B 245M 1.67B 648M 8.44B 659M 645M 27.97B
Net income -146M -170M -21.67M -18.6M -17.46M -15.95M -30.1M -2.07B -30.24M -207M -80.08M -1.04B -81.38M -79.62M -3.45B 44.25M 51.59M 6.58M 5.65M 5.3M 4.84M 9.14M 628M 9.18M 62.74M 24.32M 317M 24.71M 24.17M 1.05B
Net Debt 68.7M 80.09M 10.22M 8.77M 8.23M 7.52M 14.19M 975M 14.26M 97.41M 37.75M 492M 38.36M 37.53M 1.63B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
-
Date Price Change Volume
27/08/26 HK$1.980 -1.00% 73,400
26/08/26 HK$2.000 +0.50% 148,400
25/08/26 HK$1.990 +6.42% 203,800
24/08/26 HK$1.870 -4.10% 162,400
21/08/26 HK$1.950 -10.14% 633,400
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.715CNY
Average target price
9.801CNY
Spread / Average Target
+471.35%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock